Akums Drugs

Akums Drugs & Pharmaceuticals is India's largest contract development and manufacturing organization (CDMO), specializing in a wide array of pharmaceutical formulations. Established in 2004, the company produces approximately 12% of all drugs consumed in India, serving both domestic leaders and global multinational corporations. Their manufacturing infrastructure includes over 10 state-of-the-art facilities capable of producing tablets, hard and soft gelatin capsules, injectables, and specialized delivery systems. Beyond manufacturing, Akums provides end-to-end solutions including formulation R&D, regulatory support, and clinical trial management. The company recently transitioned to a public entity following a successful IPO in 2024, reflecting its dominant position in the pharmaceutical supply chain. With a focus on quality and innovation, Akums continues to expand its capabilities into complex generics and biologics.